Enoxaparin

Your blood clotting system involves a cascade of proteins called clotting factors that work together to form a blood clot ^{[1, 2]}. Two key factors in this cascade are Factor Xa (which activates thrombin) and thrombin (Factor IIa) itself (which converts fibrinogen into fibrin, the structural material of clots).

Enoxaparin works by enhancing the activity of a natural anticoagulant protein called antithrombin III (AT-III) ^{[1, 3]}. Normally, antithrombin slowly inactivates clotting factors. When enoxaparin binds to antithrombin, it dramatically accelerates this inactivation — particularly of Factor Xa ^{[1, 2]}.

Compared to regular (unfractionated) heparin, enoxaparin has several important differences ^{[1, 3, 4]}:

- Preferentially targets Factor Xa — with an anti-Xa to anti-IIa ratio of approximately 3.8:1 (vs. 1:1 for unfractionated heparin) - More predictable pharmacokinetics — consistent absorption from subcutaneous injection, allowing fixed-dose or weight-based dosing without routine monitoring - Longer duration of action — typically dosed once or twice daily instead of continuous IV infusion - Lower risk of heparin-induced thrombocytopenia (HIT) — approximately 0.1% vs. 1-3% for unfractionated heparin ^{[4, 5]}

These advantages have made enoxaparin the most widely used anticoagulant for inpatient and outpatient treatment and prevention of blood clots.

Enoxaparin is given as a subcutaneous injection, most commonly in the abdominal area ^{[1, 2]}.

For prevention (post-surgery): Injections typically begin within hours of surgery and continue for 7-14 days (or longer for high-risk patients). You will receive once-daily injections.

For treatment (DVT/PE): Treatment doses are given once or twice daily. Many patients can be treated at home with self-injections, avoiding prolonged hospitalization ^[4]. Treatment typically bridges to a long-term oral anticoagulant (warfarin or a DOAC).

Self-injection tips [1]: - Inject into the fatty tissue of the abdomen (at least 2 inches from the navel) - Alternate sides with each injection - Do NOT rub the injection site afterward — press gently with gauze - Bruising at the injection site is common and expected - The prefilled syringe has a safety mechanism — the needle retracts after injection

What to expect: The injection may cause a brief stinging sensation. Bruising at the injection site is very common (up to 50% of patients). Small, firm nodules may develop at injection sites.

Important [1]: Report any unusual bleeding, dark/tarry stools, blood in urine, excessive bruising, or signs of blood clots (leg swelling, chest pain, shortness of breath) immediately.

Food [1]: Enoxaparin is administered by injection and is not affected by food intake. There are no dietary restrictions specific to enoxaparin.

Vitamin K foods [1]: Unlike warfarin, enoxaparin does not require dietary vitamin K restriction. You can eat green leafy vegetables, broccoli, and other vitamin K-rich foods without affecting enoxaparin efficacy.

Alcohol [1]: Excessive alcohol consumption increases bleeding risk and can cause liver damage, which may worsen coagulation. Moderate alcohol consumption is generally acceptable during short-term enoxaparin use. Discuss with your doctor.

Cranberry juice: Unlike warfarin (where cranberry juice may interact), cranberry juice does not significantly affect enoxaparin.

DVT/PE prophylaxis — orthopedic surgery [1, 2]: - Hip replacement: 30 mg SC every 12 hours, or 40 mg SC once daily. Start 12-24 hours post-surgery. Duration: 7-10 days (up to 35 days for extended prophylaxis) - Knee replacement: 30 mg SC every 12 hours. Start 12-24 hours post-surgery. Duration: 7-10 days

DVT/PE prophylaxis — medical patients [1]: - 40 mg SC once daily. Duration: 6-14 days

DVT treatment (with or without PE) [1, 4]: - Outpatient (DVT without PE): 1 mg/kg SC every 12 hours - Inpatient: 1 mg/kg SC every 12 hours, OR 1.5 mg/kg SC once daily - Continue for minimum 5 days AND until oral anticoagulant is therapeutic

Acute coronary syndromes (with aspirin) [1, 5]: - Unstable angina/NSTEMI: 1 mg/kg SC every 12 hours (with aspirin 100-325 mg) - STEMI: 30 mg IV bolus + 1 mg/kg SC, then 1 mg/kg SC every 12 hours

Renal impairment (CrCl <30 mL/min) [1]: - Prophylaxis: 30 mg SC once daily - Treatment: 1 mg/kg SC once daily (NOT every 12 hours) - Consider anti-Xa level monitoring

Obesity [1]: Weight-based dosing (1 mg/kg). For patients >150 kg, consider anti-Xa level monitoring.

Generic enoxaparin (biosimilar) has been available since 2012 ^{[6, 7]}.

Pricing comparison [6, 7]: - Generic enoxaparin: $50-200/month (varies widely by dose and duration) - Brand Lovenox: $300-800/month - Savings: approximately 50-75% with generic - Prefilled syringes are more convenient but may cost more than multi-dose vials

Insurance coverage: Generic enoxaparin is covered by most insurance plans, though copays can vary ^[7].

Cost-saving tips: - Generic prefilled syringes offer convenience and safety (no dosing errors) - For short-term prophylaxis (7-14 days), total cost is limited - GoodRx coupons can significantly reduce cash prices - Patient assistance programs available from Sanofi (brand Lovenox) - For long-term anticoagulation, switching to a DOAC (oral) may be more convenient and comparable in cost

Pregnancy [1, 2]: Enoxaparin does not cross the placenta in clinically significant amounts and is the anticoagulant of choice during pregnancy for many indications ^{[1, 8]}: - Treatment and prevention of venous thromboembolism in pregnancy - Antiphospholipid syndrome - Mechanical heart valve anticoagulation (controversial, but commonly used)

Warfarin is teratogenic and DOACs lack pregnancy safety data, making LMWH the standard of care. Dose adjustments may be needed as pregnancy progresses due to increased volume of distribution and renal clearance. Anti-Xa levels may be monitored.

Important: Discontinue enoxaparin 24 hours before planned delivery or epidural placement to reduce spinal hematoma risk ^[1].

Breastfeeding [1, 9]: Enoxaparin is a large molecule that is poorly absorbed orally. Even if small amounts enter breast milk, the infant would not absorb it from the GI tract. Enoxaparin is considered compatible with breastfeeding ^[9].

Generic enoxaparin has been available since 2012 ^{[6, 7]}.

Available formulations: - Prefilled syringes: 30, 40, 60, 80, 100, 120, 150 mg - Multi-dose vial: 300 mg/3 mL (for institutional use)

Biosimilar note [6]: The FDA-approved generic enoxaparin (by Sandoz) was the first generic version of a LMWH. It met bioequivalence standards including pharmacokinetic, pharmacodynamic, and clinical endpoint comparisons.

Brand vs. generic: No clinically meaningful differences in efficacy or safety.

Prefilled syringes: Both brand and generic offer prefilled syringes with safety mechanisms to prevent needlestick injuries. These are preferred for patient self-injection.